| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.04 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |